This seven-year outcomes study is critical to the success of a compound that is expected to build on the sponsor’s
leadership position in diabetes care.
Acurian reads the pulse of CV studies.
We create a rhythm that will keep your trials on time and on budget, using data you can trust. Plus, we have a track record of resuscitating trials losing ground to attrition.
From atrial fibrillation to hypertension and stroke, we put our hearts into every aspect of patient enrollment and retention for these critical indications.
Acurian has recruited and enrolled thousands of patients for more than 60 pharmaceutical
and biotech companies representing over 4,500 research sites.